Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) research hub

Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I)

This study is looking into a new medication called BBP-418 (also known as ribitol) for people with a muscle condition called Limb-Girdle Muscular Dystrophy type 2I (LGMD2I). It aims to see if the medication is safe and helps improve their condition.